@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix dc: . @prefix xsd: . @prefix owl: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-JG5CGZN8-C skos:prefLabel "Agents adrénergiques"@fr, "Adrenergic Agents"@en ; a mesh:Descriptor, skos:Concept . jvr:-FH8C43MZ-4 skos:prefLabel "Phénéthylamines"@fr, "Phenethylamines"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-ZR9Q784C-Z . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-VW6HW8D1-F skos:prefLabel "Propanolamines"@fr, "Propanolamines"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-ZR9Q784C-Z . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G36QLBD8-4 skos:prefLabel "Central Nervous System Stimulants"@en, "Stimulants du système nerveux central"@fr ; a mesh:Descriptor, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R9SB4WRS-X skos:prefLabel "Vasoconstricteurs"@fr, "Vasoconstrictor Agents"@en ; a mesh:Descriptor, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-ZR9Q784C-Z mesh:allowableQualifier jvr:-G4R176S9-J, jvr:-CB30NGKB-3, jvr:-T9HQD7ST-J, jvr:-TJHVZCRZ-0, jvr:-NB0XHT3S-N, jvr:-XV06LPML-W, jvr:-R3QWLHRG-V, jvr:-THHNVC7V-3, jvr:-NHL3D2X0-S, jvr:-D0F21513-5, jvr:-Q3979798-W, jvr:-W6SQV79N-S, jvr:-G30ZJ446-J, jvr:-L6C0XPHT-4, jvr:-HQRFT0C6-B, jvr:-H7K65Q8S-Z, jvr:-FWD2BGQ0-9, jvr:-NFTHND7Q-8, jvr:-M63HSDM7-1, jvr:-BT300B3G-Q, jvr:-R0ZCQ8X6-J, jvr:-S0CS1X5R-5, jvr:-SBNWSM1T-R, jvr:-WK5F724J-1, jvr:-NKM836P1-M ; dc:created "1999-01-01"^^xsd:date ; skos:altLabel "U6X61U5ZEG"@fr, "U6X61U5ZEG"@en, "NLJ6390P1Z"@fr, "NLJ6390P1Z"@en, "299-42-3 (Ephedrine)"@fr, "299-42-3 (Ephedrine)"@en, "(1R,2S)-2-methylamino-1-phenyl-propan-1-ol"@en, "(1R,2S)-2-methylamino-1-phenyl-propan-1-ol"@fr, "GN83C131XS"@fr, "GN83C131XS"@en, "Erythro Isomer of Ephedrine"@en ; skos:broader jvr:-FH8C43MZ-4, jvr:-VW6HW8D1-F ; a skos:Concept, mesh:Descriptor ; mesh:pharmacologicalAction jvr:-G36QLBD8-4, jvr:-JG5CGZN8-C, jvr:-R9SB4WRS-X, jvr:-PF128B09-N ; dc:established "1966-01-01"^^xsd:date ; skos:hiddenLabel "Sulfate d'éphédrine"@fr, "Ephedrine Hydrochloride"@en, "Éphédrine sulfate"@fr, "Sal-Phedrine"@en, "Chlorhydrate d'éphédrine"@fr, "Ephedrine Renaudin"@en, "Ephedrine Sulfate"@en ; skos:prefLabel "Ephedrine"@en, "Éphédrine"@fr ; skos:inScheme jvr: ; owl:sameAs ; skos:definition "A phenethylamine found in EPHEDRA SINICA. PSEUDOEPHEDRINE is an isomer. It is an alpha- and beta-adrenergic agonist that may also enhance release of norepinephrine. It has been used for asthma, heart failure, rhinitis, and urinary incontinence, and for its central nervous system stimulatory effects in the treatment of narcolepsy and depression. It has become less extensively used with the advent of more selective agonists."@en ; dc:modified "2016-07-05"^^xsd:date . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-PF128B09-N skos:prefLabel "Sympathomimétiques"@fr, "Sympathomimetics"@en ; a mesh:Descriptor, skos:Concept .